Home » FDA Clears Two RF Medical Radiofrequency Ablation Products
FDA Clears Two RF Medical Radiofrequency Ablation Products
Two RF Medical ablation systems — Mygen M-3004 and Myoblate — have received FDA marketing clearance for treating damaged tissue and tumors.
Mygen M-3004 generates radiofrequency (RF) energy with compatible electrodes to destroy abnormal tissue, targeting lesions of varied shapes and sizes.
The Myoblate specialized electrode, a part of the company’s RF ablation system, was FDA cleared for treatment of uterine fibroids, as a minimally invasive alternative to hysterectomy.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct